Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IMVT

Immunovant, Inc.

CIK 0001764013 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$44.37
↑ 0.02 (0.05%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$9.16B
P/E Ratio
-17.03
EPS
-2.77
Dividend Yield
Not covered
52W Position
97%
Beta
1.33

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
12.46
P/S
Not covered
EV/Revenue
Not covered
ROE
-73.2%
Valuation data covers 8,725/9,697 US-listed stocks (90.0%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 97%
$14.47$45.42

Latest Financials

2026-03-31 FY
Revenue
–
Net Income
-$505.61M
Total Assets
$957.01M
Free Cash Flow
-$407.32M

Recent news